Where does Metabolix, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Metabolix, Inc. ranks #21,440 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Metabolix, Inc. hold?

Metabolix, Inc. holds 13 US utility patents granted between 2015 and 2016, spanning 15 technology areas.

What is Metabolix, Inc.'s Innovation Score?

Metabolix, Inc. has an Innovation Score of 35.5 out of 100 (top 49% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Metabolix, Inc. focus on?

Metabolix, Inc.'s top technology area is C08L (Compositions OF Macromolecular Compounds) with 8 patents, ranking #437 of 2,352 assignees active in that subclass. Grants appear in 15 CPC subclasses total.

Is Metabolix, Inc.'s patent grant rate increasing or decreasing?

Metabolix, Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Metabolix, Inc.'s patents?

Metabolix, Inc.'s patents average 21.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Metabolix, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Metabolix, Inc.

USPTO PatentsView assignee record - 13 granted patents across 15 technology areas, recorded in grant years 2015–2016. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C08L (Compositions OF Macromolecular Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Metabolix ranks #21,440 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 15 technology areas.

#21,440
of 49,997 US assignees by volume: Top 49%
by Innovation Score (35.5/100): 21.2
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R21440 · US Corporation #21,440 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #21,440/49,997
PHOTO-FINISH Medica
CPC-FOCUS C08L · 15 areas
INNOV-THIN 35.5/100
CLAIMS-DENSE 21.2 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Medica Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Metabolix’s 35.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.1 pts (26%) Velocity 0.0 pts (0%) Breadth 13.7 pts (39%) Claim depth 12.7 pts (36%)

Qualcomm Incorporated · highest

85
Metabolix · this assignee

36
3D Lighting… · lowest

7

What this shows Metabolix's Innovation Score is 35.5/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Metabolix?

Each dot is one of Metabolix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Metabolix’s own 21.2 claims/patent is ABOVE the 14.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Metabolix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Metabolix's grants concentrate

Metabolix, Inc. is a focused PatentsView assignee: 15 CPC subclasses with 61.5% of grants classified under C08L (Compositions OF Macromolecular Compounds). Peak complete grant year is 2015 (7 grants) versus a trough of 6 in 2016. By volume, Metabolix sits between Medica Corporation and Mindtronic AI Co., Ltd..

Medica

13
Meharry Medical C…

13
Mercury Kingdom A…

13
Mesaplexx Pty

13
Metran

13
Michigan Tube Swa…

13
Microsoft Israel…

13
Mindtronic AI

13
Metabolix ◀

13

What this shows Metabolix holds 13 patents at rank #21,461, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Metabolix

By rank, the assignees closest to #21,461 in granted patent volume.

Leaders in C08L (Compositions OF Macromolecular Compounds)

Other assignees with the most granted patents in Metabolix's primary technology class.

Metabolix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 49% higher than 51% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2016

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Metabolix, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	7	53.8%
2016	6	46.2%

Which technologies does Metabolix, Inc. patent most?

C08L - Compositions OF Macromolecular Compounds 8

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 6

Y10T - Technical Subjects Covered BY Former US Classification 4

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 3

C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients 3

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

B32B - Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form 2

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 2

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 1

C07D - Heterocyclic Compounds 1

A45D - Hairdressing OR Shaving Equipment ; Equipment FOR Cosmetics OR Cosmetic Treatments, e.g. FOR Manicuring OR Pedicuring 1

C07C - Acyclic OR Carbocyclic Compounds 1

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

C09D - Coating Compositions, e.g. Paints, Varnishes OR LACQUERS; Filling PASTES; Chemical Paint OR INK REMOVERS; INKS; Correcting FLUIDS; WOODSTAINS; Pastes OR Solids FOR Colouring OR PRINTING; USE OF Materials Therefor 1

B29B - Preparation OR Pretreatment OF THE Material TO BE SHAPED; Making Granules OR PREFORMS; Recovery OF Plastics OR Other Constituents OF Waste Material Containing Plastics 1

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Metabolix, Inc.'s patent record in context - here's where to go next.

Metabolix, Inc.'s lead technology class is C08L (Compositions OF Macromolecular Compounds), 61.5% of its portfolio - see every assignee active in that class. Explore C08L
Ranked #21,440 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Metabolix, Inc. against Medica Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.